Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
株式のランク #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
株価
$0.14942078
最終同期: 2025-05-15
時価総額
$3.86M
変化(1日)
0.10%
変化(1年)
0.00%
DE
取引 Medigene AG (MDG1)

カテゴリー

Medigene AG(MDG1)の株価履歴
終値の最高値: $0.15 (2025-05-01)

終値の最安値: $485.97 (2000-06-01)
Medigene AG の株価履歴(2000 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2025 -86.77%
2024 -62.95%
2023 -30.06%
2022 -29.39%
2021 -24.90%
2020 -16.27%
2019 -42.37%
2018 -38.37%
2017 36.28%
2016 46.54%
2015 44.80%
2014 3.96%
2013 -9.91%
2012 0.94%
2011 -50.52%
2010 -49.02%
2009 6.35%
2008 -36.07%
2007 -14.51%
2006 -12.21%
2005 -5.50%
2004 40.71%
2003 93.97%
2002 -80.04%
2001 -73.85%
2000 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE